Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound paclitaxel + carboplatin in advanced ovarian cancer NACT
NCT05316376Phase 2Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- May 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT05316376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316376.